Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid
Female Reproductive Organ Cancer
Chang Gung Memorial HospitalSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
49 Active assets in the Female Reproductive Organ Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Adriamycin AstraZeneca | Phase 2 | BB |
Carboplatin AbbVie | Phase 2/3 | BB |
Indocyanine Green Istanbul University | Phase 4 | BB |
Normal Human Serum Albumin Joachim Zdolsek | Phase 4 | B |
Nivolumab Clovis Oncology, Inc. | Phase 2 | B |
View all 50 →
Same molecule, other indications
Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →